Cite
HARVARD Citation
Harrer, A. et al. (2020). Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death‐1 therapies and lessons learned from natalizumab. British journal of dermatology. p. 404. [Online].